Characterization of a Novel Mouse Model for Fuchs Endothelial Corneal Dystrophy

Area of Science:

• Ophthalmology
• Corneal Diseases
• Animal Models

Background:

• Fuchs endothelial corneal dystrophy (FECD) is a progressive blinding disorder.
• Key symptoms include corneal endothelial excrescences (guttae), cell loss, and edema.
• Current understanding is limited by the lack of a comprehensive animal model.

Purpose of the Study:

• To develop a novel, comprehensive animal model for FECD.
• To investigate signaling pathways involved in FECD progression.
• To facilitate the development of early intervention strategies.

Main Methods:

• Generated a double mutant mouse with tamoxifen-inducible knockdown of Slc4a11 and a Col8a2 (Q455K) mutation.
• Utilized optical coherence tomography (OCT) and in vivo confocal microscopy for corneal analysis.
• Performed histopathology, immunofluorescence staining, and lactate assays to assess disease characteristics and endothelial function.

Main Results:

• The developed mouse model displayed guttae, increased corneal thickness, and reduced endothelial cell density.
• Endothelial cells showed altered morphology, disrupted adherens junctions, and elevated reactive oxygen species (ROS).
• Elevated stromal lactate concentrations indicated compromised endothelial pump function.

Conclusions:

• The generated mouse model effectively recapitulates the major phenotypic features of FECD.
• This model provides a valuable tool for studying FECD pathogenesis.
• It will aid in the development and testing of therapeutic interventions for FECD.